// App-Quantinova.ai

: Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Researchers

Presenter

  • Michael Wang

Principal Investigators

  • Pier Luigi Zinzani

  • Andre Goy

  • Olivier Casasnovas

  • Stephen D. Smith

  • Gandhi Damaj

  • Jeanette K. Doorduijn

  • Thierry Lamy

  • Franck Morschhauser

  • Carlos Panizo

  • Bijal D. Shah

  • Andrew Davies

  • Richard Eek

  • Jehan Dupuis

  • Eric Jacobsen

  • Arnon P. Kater

  • Steven LE Gouill

  • Lucie Oberic

  • Tadeusz Robak

  • Richa Dua

  • Melanie M. Frigault

  • Raquel Izumi

  • Dorothy Nguyen

  • Priti Patel

  • Ming Yin

  • Wojciech Jurczak

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Plymouth University Medical School, Plymouth, United Kingdom

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • John Theurer Cancer Ctr At Hackensack Univ Med Ctr, Hackensack, NJ

  • CHU Dijon - Hôpital d'Enfants, Dijon, France

  • University of Washington and Fred Hutchinson Cancer Center, Seattle, WA

  • Department of Pathology, Rouen University Hospital, Rouen, France

  • Erasmus MC, HOVON Lunenburg Lymphoma Phase I/II Consortium, Rotterdam, Netherlands

  • CHU Rennes, Rennes, France

  • Hopital Claude Huriez, Lille, France

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Moffitt Cancer Center, Tampa, FL

  • Cancer Sciences, University of Southampton, Southampton, United Kingdom

  • Border Medical Oncology, Albury-Wodonga, Australia

  • Lymphoid Malignancies Unit, Henri Mondor University Hospital, APHP, Créteil, France

  • Dana-Farber Cancer Institute, Boston, MA

  • Academic Medical Center, Lunenburg Lymphoma Phase I/II Consortium, Amsterdam, Netherlands

  • CHU de Nantes - Hotel Dieu, Nantes, France

  • Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland

  • Acerta Pharma, South San Francisco, CA

  • Department of Hematology, Jagiellonian University Hospital, Krakow, Poland

Locations

  • United States

  • United Kingdom

  • Italy

  • France

  • Netherlands

  • Spain

  • Australia

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

Biomarkers

  • Bruton tyrosine kinase

Drug/Treatment

  • ACP-196

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved